10 Feb Minaris Regenerative Medicine
Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years’ experience providing outstanding quality and reliability. Our facilities in the US, Europe, and Asia allow us to supply patients worldwide with life-changing therapies. The vision of Minaris Regenerative Medicine is “creating future cell therapy miracles together” and its mission is to “commit our experience to our clients, by providing global manufacturing services, development solutions, and technologies for cell and gene therapies to improve society’s well-being.” Our U.S. facilities hold all requisite licensures and maintain GMP-compliant quality systems. Our European facilities are compliant with all EU regulations and general FDA guidelines, hold all licenses for different types of complex cell and gene therapy products falling under the EU definition of Advanced Therapy Medicinal Products (ATMP). Our Yokohama facility is designed for compliance with Japanese regulations and is authorized to manufacture regenerative medicine products.
